On August 31, 2026, the Board of Directors approved a new $250 million share repurchase program for Mirion Technologies' Class A common stock. The program is effective immediately and remains valid through August 31, 2031, unless terminated earlier. This authorization substantially completes the previous $100 million program, which saw approximately 2.6 million shares repurchased for about $40 million in the third quarter of 2026. The company intends to execute buybacks via open market purchases, block trades, or other methods consistent with Rule 10b-18. Mirion Technologies operates in the nuclear technology sector, providing radiation detection and measurement solutions.

Mirion Technologies, Inc. reported second quarter 2026 financial results, with revenues increasing 19.7% to $266.8 million compared to $222.9 million in the prior year period. GAAP net income decreased 4.7% to $8.1 million, while Adjusted EBITDA rose 27.5% to $65.3 million. Second quarter orders reached $291 million, a 40% increase year-over-year including acquisitions. The company reaffirmed its full-year 2026 guidance, projecting total revenue growth of 22.0% to 24.0% and Adjusted EPS of $0.48 to $0.55 per share. Mirion Technologies operates in the radiation detection, measurement, analysis, and monitoring industry, serving nuclear, medical, defense, and research markets.

Mirion Technologies, Inc. entered into a letter agreement and secondment addendum with Loïc Eloy, President of the Nuclear & Safety Group, in connection with his expatriation assignment from France to the United States. Mr. Eloy will receive an annual base salary of USD 415,000 with a 50% target bonus opportunity and customary expatriation-related benefits. Mirion Technologies, Inc. operates in the nuclear and safety technology sector, providing radiation detection and control solutions.